Page 31 - Glucose Monitoring Devices

26 CHAPTER 1 Introduction to SMBG

[62] Holman R, Paul S, Bethel M, Matthews D, Neil H. 10-Year follow-up of intensive
glucose control in type 2 diabetes. New England Journal of Medicine 2008;359:
1577e89. https://doi.org/10.1056/nejmoa0806470.
[63] Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven P, et al. Glucose
control and vascular complications in Veterans with type 2 diabetes. New England
Journal of Medicine 2009;360:129e39. https://doi.org/10.1056/nejmoa0808431.
[64] Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
New England Journal of Medicine 2008;358:2560e72. https://doi.org/10.1056/
nejmoa0802987.
[65] Effects of intensive glucose lowering in type 2 diabetes. New England Journal of Med-
icine 2008;358:2545e59. https://doi.org/10.1056/nejmoa0802743.
[66] Ismail-Beigi F, Craven T, Banerji M, Basile J, Calles J, Cohen R, et al. Effect of inten-
sive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an
analysis of the ACCORD randomised trial. The Lancet 2010;376:419e30. https://
doi.org/10.1016/s0140-6736(10)60576-4.
[67] Skyler J, Bergenstal R, Bonow R, Buse J, Deedwania P, Gale E, et al. Intensive glyce-
mic control and the prevention of cardiovascular events: implications of the ACCORD,
ADVANCE, and VA diabetes trials. Journal of the American College of Cardiology
2009;53:298e304. https://doi.org/10.1016/j.jacc.2008.10.008.
[68] Davis W, Bruce D, Davis T. Is self-monitoring of blood glucose appropriate for all type
2 diabetic patients?: the Fremantle diabetes study. Diabetes Care 2006;29:1764e70.
https://doi.org/10.2337/dc06-0268.
[69] Davis W, Bruce D, Davis T. Does self-monitoring of blood glucose improve outcome
in type 2 diabetes? The Fremantle Diabetes Study. Diabetologia 2007;50:510e5.
https://doi.org/10.1007/s00125-006-0581-0.
[70] Martin S, Schneider B, Heinemann L, Lodwig V, Kurth H, Kolb H, et al. Self-
monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemio-
logical cohort study. Diabetologia 2005;49:271e8. https://doi.org/10.1007/s00125-
005-0083-5.
[71] Karter A, Parker M, Moffet H, Spence M, Chan J, Ettner S, et al. Longitudinal study of
new and prevalent use of self-monitoring of blood glucose. Diabetes Care 2006;29:
1757e63. https://doi.org/10.2337/dc06-2073.
[72] Elgart J, Gonza ´lez L, Prestes M, Rucci E, Gagliardino J. Frequency of self-monitoring
blood glucose and attainment of HbA1c target values. Acta Diabetologica 2015;53:
57e62. https://doi.org/10.1007/s00592-015-0745-9.
[73] Harris M. Frequency of blood glucose monitoring in relation to glycemic control in
patients with type 2 diabetes. Diabetes Care 2001;24:979e82. https://doi.org/
10.2337/diacare.24.6.979.
[74] Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, et al. Impact of self
monitoring of blood glucose in the management of patients with non-insulin treated
diabetes: open parallel group randomised trial. British Medical Journal 2007;335:
132. https://doi.org/10.1136/bmj.39247.447431.be.
[75] Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A. Cost effectiveness of self moni-
toring of blood glucose in patients with non-insulin treated type 2 diabetes: economic
evaluation of data from the DiGEM trial. British Medical Journal 2008;336:1177e80.
https://doi.org/10.1136/bmj.39526.674873.be.
[76] O’Kane M, Bunting B, Copeland M, Coates V. Efficacy of self monitoring of blood
glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised
controlled trial. British Medical Journal 2008;336:1174e7. https://doi.org/10.1136/
bmj.39534.571644.be.